Dr. Robert Michael Massanari, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 930 Hemlock Loop, Lynden, WA 98264 Phone: 360-922-0063 |
News Archive
Insights from a genetic condition that causes brain cancer are helping scientists better understand the most common type of brain tumor in children.
The inflammasome — a protein signaling network that is activated to rid the body of virus or bacteria-infected cells — may play an important role in triggering an immune response to cancer and causing an existing class of drugs to work better against cancers.
Seattle Genetics Inc. has finally obtained the U.S. Food and Drugs Administration (FDA) nod for a second type of blood cancer drug. The FDA advisory committee voted 10-0 on Thursday to recommend accelerated approval of the drug, under the proposed trade name Adcetris, for anaplastic large cell lymphoma (ALCL). The panel earlier unanimously approved the drug for Hodgkin's lymphoma, another type of blood cancer.
"Institutional donor aid in 2010 was at its highest-ever level - US$16.7 billion - but so were aid costs," according to preliminary estimates in the annual report of the international aid watchdog Development Initiatives released on Wednesday, IRIN reports.
› Verified 8 days ago